{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-084908","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.345101+00:00","generated_at":"2026-05-31T13:41:09.097573+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CytoSorbents regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq letter on July 26, 2024 confirming compliance after closing bid price at $1.00+ for 10 consecutive days through July 25.","Previously, on May 22, 2024, Nasdaq notified CytoSorbents of non-compliance due to bid price below $1.00 for 30 consecutive days.","Compliance had to be achieved by November 16, 2024; the company regained compliance early from July 12 to July 25.","CEO Dr. Phillip Chan stated the company is now in full compliance, strengthening its position ahead of expected DrugSorb-ATR regulatory submissions.","CytoSorbents continues aggressive cost cutting and operational progress on clinical, regulatory, and manufacturing fronts."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-084908","json":"https://secwatch.observer/filing/0001104659-24-084908.json","markdown":"https://secwatch.observer/filing/0001104659-24-084908.md","text":"https://secwatch.observer/filing/0001104659-24-084908.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924084908/0001104659-24-084908-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924084908/tm2420569d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:41:09.097573+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}